Oxidative stress and thromboxane-dependent platelet activation in inflammatory bowel disease: effects of anti-TNF-α treatment

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Thrombosis and Haemostasis

• Publication date

  2016-08-30

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1160/TH16-02-0167PMID 27305860
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anti-TNFα agents curb platelet activation in patients with rheumatoid arthritis

  2016cited by this paper
• Hyaluronan based hydrogels provide an improved model to study megakaryocyte-matrix interactions.

  2016cited by this paper
• Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?

  2015cited by this paper
• Oxidative stress in chronic vascular disease: From prediction to prevention.

  2015cited by this paper
• Epidemiology, risk factors and management of cardiovascular diseases in IBD

  2015influential reference
• Mean Platelet Volume in Crohn’s Disease Patients Predicts Sustained Response to a 52-Week Infliximab Therapy: A Pilot Study

  2015cited by this paper
• Predicting Endoscopic Disease Activity in Crohn's Disease: A New and Validated Noninvasive Disease Activity Index (The Utrecht Activity Index)

  2015cited by this paper
• Hypercoagulability and Platelet Abnormalities in Inflammatory Bowel Disease

  2015cited by this paper
• The Contribution of CD40/CD40L Axis in Inflammatory Bowel Disease: An Update

  2015cited by this paper
• Platelets in Inflammation and Atherogenesis

  2015cited by this paper
• Inflammatory bowel disease and risk of coronary heart disease.

  2015cited by this paper
• Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis.

  2014cited by this paper
• Risk of venous thromboembolism in patients with rheumatoid arthritis: a systematic review and meta-analysis

  2014cited by this paper
• Venous and arterial disease in inflammatory bowel disease

  2013cited by this paper
• Platelet Abnormalities during Colonic Inflammation

  2013cited by this paper
• Recent advances in understanding Crohn’s disease

  2013cited by this paper
• Biomarkers of platelet activation in acute coronary syndromes

  2012cited by this paper
• Recent advances in understanding ulcerative colitis

  2012cited by this paper
• Involvement of coagulation and hemostasis in inflammatory bowel diseases.

  2012cited by this paper
• Platelet Function in Health and Disease: from Molecular Mechanisms, Redox Considerations to Novel Therapeutic Opportunities

  2012cited by this paper
• cagA structural types of Helicobacter pylori strains isolated from patients with gastric carcinoma and chronic gastritis only

  2012cited by this paper
• Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress.

  2010cited by this paper
• Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-α treatment

  2010cited by this paper
• Inflammatory bowel disease: A paradigm for the link between coagulation and inflammation

  2009cited by this paper
• Matrix metalloproteinase 9 is involved in Crohn’s disease-associated platelet hyperactivation through the release of soluble CD40 ligand

  2008cited by this paper
• Reduction of oxidative stress marker levels by anti-TNF-alpha antibody, infliximab, in patients with rheumatoid arthritis.

  2008cited by this paper
• TNFα blockade in human diseases: Mechanisms and future directions

  2008cited by this paper
• TNFalpha blockade in human diseases: mechanisms and future directions.

  2008cited by this paper
• Platelet activation and atherothrombosis.

  2007cited by this paper
• Functional modulation of Crohn's disease myofibroblasts by anti-tumor necrosis factor antibodies.

  2007cited by this paper
• TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease.

  2006cited by this paper
• TNF-α Blockade Down-Regulates the CD40/CD40L Pathway in the Mucosal Microcirculation: A Novel Anti-Inflammatory Mechanism of Infliximab in Crohn’s Disease1

  2006cited by this paper
• Platelets in inflammation and atherogenesis.

  2005cited by this paper
• Platelets in Inflammatory Bowel Disease: Clinical, Pathogenic, and Therapeutic Implications

  2004cited by this paper
• Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients.

  2003cited by this paper
• Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn’s disease

  2003cited by this paper
• Platelet aggregation and neutrophil sequestration in the mesenteric circulation in inflammatory bowel disease.

  1997cited by this paper
• Thrombopoietin directly and potently stimulates multilineage growth and progenitor cell expansion from primitive (CD34+ CD38-) human bone marrow progenitor cells: distinct and key interactions with the ligands for c-kit and flt3, and inhibitory effects of TGF-beta and TNF-alpha.

  1997cited by this paper
• Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man.

  1995cited by this paper
• Platelets in ulcerative colitis and Crohn's disease express functional interleukin‐1 and interleukin‐8 receptors

  1994cited by this paper
• Platelets circulate in an activated state in inflammatory bowel disease.

  1994cited by this paper
• Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.

  1989cited by this paper
• Fractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in man.

  1989cited by this paper
• Platelet activation in unstable coronary disease.

  1986cited by this paper
• Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

  1976cited by this paper

• Characteristics of gut microbiota and metabolites in patients with ulcerative colitis with fatigue

  2026cites this paper
• Ellagic acid-imbedded MoO3 nanowires architecture: External mediator-less electrochemical immunoprobing of inflammatory bowel disease marker.

  2025cites this paper
• Prostaglandins and Inflammatory Bowel Disease: From Mechanism to Clinic.

  2025cites this paper
• Thrombosis and inflammatory bowel disease.

  2024cites this paper
• Low Weight Polysaccharide of Hericium erinaceus Ameliorates Colitis via Inhibiting the NLRP3 Inflammasome Activation in Association with Gut Microbiota Modulation

  2023cites this paper
• Recent progress in plant-derived polysaccharides with prebiotic potential for intestinal health by targeting gut microbiota: a review

  2023cites this paper
• Polysaccharide from fermented mycelium of Inonotus obliquus attenuates the ulcerative colitis and adjusts the gut microbiota in mice.

  2023cites this paper
• Isinglass Polysaccharides Regulate Intestinal-Barrier Function and Alleviate Obesity in High-Fat Diet Mice through the HO-1/Nrf2 Pathway and Intestinal Microbiome Environment

  2022cites this paper
• β-glucan alleviates mice with ulcerative colitis through interactions between gut microbes and amino acids metabolism.

  2022cites this paper
• Self-assembled Micelle Derived from Pterostilbene Ameliorate Acute Inflammatory Bowel Disease.

  2022cites this paper
• Longitudinal multi-omics analysis identifies early blood-based predictors of anti-TNF therapy response in inflammatory bowel disease

  2022cites this paper
• Aronia melanocarpa (Michx.) Elliott. attenuates dextran sulfate sodium-induced Inflammatory Bowel Disease via regulation of inflammation-related signaling pathways and modulation of the gut microbiota.

  2022cites this paper
• Aloe polysaccharides ameliorate acute colitis in mice via Nrf2/HO-1 signaling pathway and short-chain fatty acids metabolism.

  2021cites this paper
• IL-1 and CD40/CD40L platelet complex: elements of induction of Crohn’s disease and new therapeutic targets

  2021cites this paper
• Revisiting an Expression Dataset of Discordant Inflammatory Bowel Disease Twin Pairs Using a Mutation Burden Test Reveals CYP2C18 as a Novel Marker

  2021cites this paper
• Inflammatory Mediators of Platelet Activation: Focus on Atherosclerosis and COVID-19

  2021cites this paper
• Venous and arterial thromboembolism in patients with inflammatory bowel diseases

  2021cites this paper
• Urinary 11‐dehydrothromboxane B2 concentrations in 20 dogs with primary immune‐mediated hemolytic anemia

  2021cites this paper
• Role of Escherichia coli in Cardiovascular Disease: Fact or Hypothesis?

  2021cites this paper
• Platelets can reflect the severity of Crohn's disease without the effect of anemia

  2020cites this paper
• Oxidative Stress Markers in Inflammatory Bowel Diseases: Systematic Review

  2020cites this paper
• The Chinese medicinal herb decoction QRZSLXF enhances anti-inflammatory effect in TNBS-induced colitis via balancing Th17/Tregs differentiation.

  2020cites this paper
• Are we choosing wisely for inflammatory bowel disease care? The IG-IBD choosing wisely campaign.

  2019cites this paper
• Protective effect and mechanism of polysaccharide from Dictyophora indusiata on dextran sodium sulfate-induced colitis in C57BL/6 mice.

  2019cites this paper
• Musca domestica Cecropin (Mdc) Alleviates Salmonella typhimurium-Induced Colonic Mucosal Barrier Impairment: Associating With Inflammatory and Oxidative Stress Response, Tight Junction as Well as Intestinal Flora

  2019cites this paper
• Effect of compound sophorae decoction on dextran sodium sulfate (DSS)-induced colitis in mice by regulating Th17/Treg cell balance.

  2019cites this paper
• A polysaccharide from cultured mycelium of Hericium erinaceus relieves ulcerative colitis by counteracting oxidative stress and improving mitochondrial function.

  2019cites this paper
• Composition characterization of oyster polysaccharides from Crassostrea hongkongensis and their protective effect against H2O2-induced oxidative damage in IEC-6 cells.

  2019cites this paper
• Efficacy of biological treatment in inflammatory bowel disease – a single-center experience

  2019cites this paper
• Correlation of Paraoxonase-1 with the Severity of Crohn’s Disease

  2018cites this paper
• Strategies to decrease oxidative stress biomarker levels in human medical conditions: A meta-analysis on 8-iso-prostaglandin F2α

  2018cites this paper
• Polysaccharide of Hericium erinaceus attenuates colitis in C57BL/6 mice via regulation of oxidative stress, inflammation-related signaling pathways and modulating the composition of the gut microbiota.

  2018cites this paper
• Significance of urinary 11-dehydro-thromboxane B2 in age-related diseases: Focus on atherothrombosis.

  2018cites this paper